A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions
Condition: Lung Cancer Interventions: Drug: Erlotinib HCl 150 mg; Drug: Tarceva® Sponsor: Quadras Scientific Solutions Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials